|Last Price$84.67||Day Change (%)0.31%|
|Open Price$84.35||Day Change ($)0.26|
|Day Range84.13–84.89||52-Week Range67.67–85.23|
As of Thu 04/17/2014 04:45 PM EST | USD
Novartis Heart Failure Pill Trial Ends Early on Positive Result
Novartis Names New Alcon, Sandoz Division Heads
UPDATE: European stocks end mixed on inflation jitters
EUROPE MARKETS: European Stocks Pare Gains After Weak Inflation Data
UPDATE: European stocks pare gains after weak inflation data
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
European stocks climb ahead of inflation data
We don't expect to change our fair value estimate for Novartis NVS after seeing the strong fourth-quarter results the firm reported Thursday. Sales were in line with our expectations, and strong growth in operating income helped Novartis improve its profitability. Growth primarily came from the ...
Enanta Pharmaceuticals Announces Detailed Data from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis being Presented at the European Association for the Study of the Liver (EASL) Meeting
Enanta Pharmaceuticals Announces Detailed Data from SAPPHIRE-I and SAPPHIRE-II Phase 3 Studies in Patients with Chronic Hepatitis C Virus Being Presented at the European Association for the Study of the Liver (EASL) Meeting